DT2216 |
Degrader (PROTAC) of BCL2L1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| BCL2L1 |
|
|
Degrader (PROTAC)
100-500 nM, maximum 1 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
No changes in BCL-2 levels in all cells examined. In addition, DT2216 had no effect on the levels ...
In Cell Selectivity Assessment
Selectivity Assessment Description:
Proteomics shows that DT2216 does not degrade any other protein.
Potency Cellular
In Vitro
BCL2L1
Mode of Action: Degrader (PROTAC)
Structure-Activity-Relationship data available? No
In Vivo Validations
Mouse
Dose: 7.5-15 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
6.3 (IP), 6.1 (IV) h
Systemic clearance:
0.42 ml/min/Kg
Reference: --
Negative Control Compounds
DT2216NC
Chemical Information
| Molecular Formula | C77H96ClF3N10O10S4 |
| SMILEs | Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCC(=O)N2CCN(CC[C@H](CSc3ccccc3)Nc3ccc(S(=O)(=O)NC(=O)c4ccc(N5CCN(CC6=C(c7ccc(Cl)cc7)CCC(C)(C)C6)CC5)cc4)cc3S(=O)(=O)C(F)(F)F)CC2)C(C)(C)C)cc1 |
| InChI | InChI=1S/C77H96ClF3N10O10S4/c1-51(53-18-20-55(21-19-53)70-52(2)82-50-103-70)83-73(96)66-44-61(92)48-91(66)74(97)71(75(3,4)5)85-68(93)16-12-9-13-17-69(94)90-42-36-87(37-43-90)35-33-59(49-102-62-14-10-8-11-15-62)84-65-31-30-63(45-67(65)104(98,99)77(79,80)81)105(100,101)86-72(95)56-24-28-60(29-25-56)89-40-38-88(39-41-89)47-57-46-76(6,7)34-32-64(57)54-22-26-58(78)27-23-54/h8,10-11,14-15,18-31,45,50-51,59,61,66,71,84,92H,9,12-13,16-17,32-44,46-49H2,1-7H3,(H,83,96)(H,85,93)(H,86,95)/t51-,59+,61+,66-,71+/m0/s1 |
| Molecular weight | 1540.58 Da |
| AlogP | 0.0 |
| HBond acceptors | 20 |
| HBond donors | 5 |
| Atoms | 201 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.